StoneX Group’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
StoneX Group's OVID Position: Q3 2026 in Review
StoneX Group opened a new position in Ovid Therapeutics (OVID) in Q3 2026: 20,782 shares worth $50.7K. The stake represents ﹤0.01% of the portfolio and ranks #1601 among its holdings.
129 funds tracked by Wall St. Rank hold OVID as of Q3 2026.
- StoneX Group held 20,782 shares of Ovid Therapeutics worth $50.7K as of Q3 2026.
- Ovid Therapeutics was a new StoneX Group position in Q3 2026.
- Ovid Therapeutics made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1601 holding.
- 129 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.
Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.